logo-loader
viewMediclinic International Plc

Mediclinic in red after write-downs at Spire and in Switzerland

Mediclinic’s bid for the outstanding 70% of Spire was rejected by the UK healthcare group

red
Lots of red at Mediclinic

Hospital group Mediclinic International Plc (LON:MDC) plunged into the red on write-offs on investments in Switzerland and Spire Healthcare PLC (LON:SPI).

Mediclinic’s bid for the outstanding 70% of Spire was rejected by the UK healthcare group in November leading to the subsequent collapse of talks.

READ: Mediclinic nudges up guidance after strong second half for its Middle East division

Spire’s value had slumped after it paid out £37mln compensation to women treated by disgraced surgeon Ian Paterson.

South Africa-based Mediclinic, which runs hospitals in Africa, Switzerland and the Middle East,  posted a loss of £492mln in the year to March after a £109mln charge for Spire and £644mln at Swiss group Hirslanden.

Mediclinic also incurred £23mln of costs rebranding its Al-Noor acquisition.

Revenues over the year were 4% higher at £2.87bn with underlying profits 3% better at £515mln.

Shares fell 4% to 650p.

Quick facts: Mediclinic International Plc

Price: 395.7 GBX

LSE:MDC
Market: LSE
Market Cap: £2.92 billion
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

NQ Minerals' David Lenigas focused on restructuring debt and upping profits...

NQ Minerals PLC's (LON:NQMI) David Lenigas speaks to Proactive London's Andrew Scott soon after taking over as chairman at the Australia-focused mining group. Production and exploration plans aside, Lenigas also says they're in advanced talks to replace on more favourable terms all the debt...

19 minutes ago

2 min read